IXC 0.00% 8.4¢ invex therapeutics ltd

Ann: Initial FDA and EMA Advice on Presendin Development, page-4

  1. 130 Posts.
    lightbulb Created with Sketch. 50
    Response from FDA is completely unclear. Have zero value for investors and unfortunately we have to wait for the full protocol and Company's decision to use or not to use vision loss as an end point. On a good side, there are no negative surprises.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.000(0.00%)
Mkt cap ! $6.312M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 65644 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 91122 2
View Market Depth
Last trade - 14.01pm 29/05/2024 (20 minute delay) ?
Last
8.2¢
  Change
0.000 ( 1.23 %)
Open High Low Volume
8.2¢ 8.2¢ 8.2¢ 20
Last updated 11.19am 29/05/2024 ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.